Clinical Trial Update: Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating imiquimod 5% cream as adjuvant treatment after curettage for nodular basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: Wake Forest University | Conditions: Basal Cell Carcinoma | Phase 4 | Status: COMPLETED